CATHETER PRECISION INC (VTAK) Fundamental Analysis & Valuation

NYSEARCA:VTAK • US74933X7084

Current stock price

0.95 USD
-0.03 (-2.56%)
Last:

This VTAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VTAK Profitability Analysis

1.1 Basic Checks

  • In the past year VTAK has reported negative net income.
  • VTAK had a negative operating cash flow in the past year.
  • In the past 5 years VTAK always reported negative net income.
  • VTAK had a negative operating cash flow in each of the past 5 years.
VTAK Yearly Net Income VS EBIT VS OCF VS FCFVTAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of VTAK (-108.34%) is worse than 82.35% of its industry peers.
  • Looking at the Return On Equity, with a value of -243.53%, VTAK is doing worse than 79.68% of the companies in the same industry.
Industry RankSector Rank
ROA -108.34%
ROE -243.53%
ROIC N/A
ROA(3y)-139.69%
ROA(5y)-139.55%
ROE(3y)-255.24%
ROE(5y)-247.84%
ROIC(3y)N/A
ROIC(5y)N/A
VTAK Yearly ROA, ROE, ROICVTAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • With an excellent Gross Margin value of 92.31%, VTAK belongs to the best of the industry, outperforming 97.86% of the companies in the same industry.
  • VTAK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VTAK Yearly Profit, Operating, Gross MarginsVTAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. VTAK Health Analysis

2.1 Basic Checks

  • VTAK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VTAK has more shares outstanding
  • The number of shares outstanding for VTAK has been increased compared to 5 years ago.
  • VTAK has a worse debt/assets ratio than last year.
VTAK Yearly Shares OutstandingVTAK Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
VTAK Yearly Total Debt VS Total AssetsVTAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • VTAK has an Altman-Z score of -29.89. This is a bad value and indicates that VTAK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -29.89, VTAK is doing worse than 91.98% of the companies in the same industry.
  • A Debt/Equity ratio of 0.48 indicates that VTAK is not too dependend on debt financing.
  • VTAK has a Debt to Equity ratio (0.48) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -29.89
ROIC/WACCN/A
WACC4.45%
VTAK Yearly LT Debt VS Equity VS FCFVTAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • VTAK has a Current Ratio of 0.10. This is a bad value and indicates that VTAK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.10, VTAK is not doing good in the industry: 96.26% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.08 indicates that VTAK may have some problems paying its short term obligations.
  • The Quick ratio of VTAK (0.08) is worse than 96.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.08
VTAK Yearly Current Assets VS Current LiabilitesVTAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. VTAK Growth Analysis

3.1 Past

  • VTAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.79%, which is quite impressive.
  • VTAK shows a strong growth in Revenue. In the last year, the Revenue has grown by 95.00%.
  • The Revenue has been growing by 25.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.21%
Revenue 1Y (TTM)95%
Revenue growth 3Y288.2%
Revenue growth 5Y25.89%
Sales Q2Q%59.73%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y49.21%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year168.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VTAK Yearly Revenue VS EstimatesVTAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
VTAK Yearly EPS VS EstimatesVTAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2023 2024 2025 2026 -200K -400K -600K -800K -1M

More info and screens

Find the best growth stocksShow best growing peers

0

4. VTAK Valuation Analysis

4.1 Price/Earnings Ratio

  • VTAK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VTAK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VTAK Price Earnings VS Forward Price EarningsVTAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VTAK Per share dataVTAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VTAK Dividend Analysis

5.1 Amount

  • VTAK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VTAK Fundamentals: All Metrics, Ratios and Statistics

CATHETER PRECISION INC

NYSEARCA:VTAK (4/21/2026, 4:15:00 PM)

0.95

-0.03 (-2.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31
Earnings (Next)05-12
Inst Owners10.18%
Inst Owner Change0%
Ins Owners14.02%
Ins Owner Change4.3%
Market Cap2.56M
Revenue(TTM)819.00K
Net Income(TTM)-17.18M
Analysts85.71
Price Target38.76 (3980%)
Short Float %1.82%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-83.91%
Min Revenue beat(2)-86.27%
Max Revenue beat(2)-81.54%
Revenue beat(4)0
Avg Revenue beat(4)-71.54%
Min Revenue beat(4)-86.27%
Max Revenue beat(4)-53.27%
Revenue beat(8)0
Avg Revenue beat(8)-68.97%
Revenue beat(12)1
Avg Revenue beat(12)-62.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.12
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-19.2
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-3.13
FCFYN/A
OCF(TTM)-3.08
OCFYN/A
SpS0.3
BVpS2.62
TBVpS-3.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -108.34%
ROE -243.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 92.31%
FCFM N/A
ROA(3y)-139.69%
ROA(5y)-139.55%
ROE(3y)-255.24%
ROE(5y)-247.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.29%
Cap/Sales 16.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.08
Altman-Z -29.89
F-Score3
WACC4.45%
ROIC/WACCN/A
Cap/Depr(3y)4.38%
Cap/Depr(5y)6.82%
Cap/Sales(3y)16.46%
Cap/Sales(5y)275.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.21%
EPS Next Y49.21%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)95%
Revenue growth 3Y288.2%
Revenue growth 5Y25.89%
Sales Q2Q%59.73%
Revenue Next Year168.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.52%
OCF growth 3YN/A
OCF growth 5YN/A

CATHETER PRECISION INC / VTAK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CATHETER PRECISION INC (VTAK) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VTAK.


What is the valuation status for VTAK stock?

ChartMill assigns a valuation rating of 0 / 10 to CATHETER PRECISION INC (VTAK). This can be considered as Overvalued.


What is the profitability of VTAK stock?

CATHETER PRECISION INC (VTAK) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CATHETER PRECISION INC?

The Earnings per Share (EPS) of CATHETER PRECISION INC (VTAK) is expected to grow by 49.21% in the next year.